Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05919511
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-05-05
Brief Title:
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Sponsor:
Incyte Corporation
Organization:
Incyte Corporation
Study Overview
Official Title:
A Prospective Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States THRIVE
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
THRIVE
Brief Summary:
The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell TransplantalloSCT and are at risk of Chronic Graft Versus Host DiseasecGVHD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None